skip to Main Content

The Outcomes of Implementing and Integrating Pharmacogenomics within Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, October 2020

Learn about peer-reviewed evidence supporting pharmacogenomics (PGx) integrated into CMM team-based care which can produce decreased costs, increased provider education and patient satisfaction, access to care and outcomes. See the demonstrated impact of PGx as a tool used during the delivery of CMM services and how it allows for precisely fitted and delivered medical care based on the unique characteristics of an individual’s genetic profile, lifestyle and environment.

Developed by the Precision Medicine Enablement via Advanced Diagnostics Workgroup.

Back To Top
×Close search

We need your help now more than ever!